Orchid Cellmark Revenues Grow by 18% and Gross Margin Increases to 38% for Third Quarter 2010

Wall Street Journal- Market Watch

PRINCETON, N.J., Nov 4, 2010 (GlobeNewswire via COMTEX) — Orchid Cellmark Inc. /quotes/comstock/15*!orch/quotes/nls/orch (ORCH 1.72, +0.09, +5.52%) , a leading international provider of identity DNA testing services, today reported revenues increased 18% to $17.3 million for the third quarter 2010, as compared to $14.7 million in the third quarter 2009. Gross margin increased to 38% and operating income in the quarter was $141 thousand.